FPF
NBSE

FNY Partners Fund’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

FNY Partners Fund’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100
Closed -$74K – 496
2017
Q4 		$74K Buy
+100
New +$38.6K 0.01% 227

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

FNY Partners Fund's NBSE Position: Q1 2018 in Review

FNY Partners Fund sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2018, closing a stake of 100 shares — an estimated $74K sold.

FNY Partners Fund first reported a position in NBSE in Q4 2017 and held it in 1 quarter. The position peaked at $74K in Q4 2017. 35 funds tracked by Wall St. Rank hold NBSE as of Q1 2018.

  • FNY Partners Fund reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • FNY Partners Fund sold 100 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $74K.
  • FNY Partners Fund first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • FNY Partners Fund's NeuBase Therapeutics, Inc. Common Stock position peaked at $74K in Q4 2017.
  • 35 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.